Managing data effectively can be challenging in any industry. But it’s especially difficult in pharmaceuticals, which faces ...

Ipsen has announced that it will be gaining exclusive global rights to Biomunex Pharmaceuticals’ pre-clinical T cell engager ...

The National Institute for Health and Care Excellence (NICE) has recommended Immunocore’s Kimmtrak (tebentafusp) as the first ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...

Gastric cancer is the fifth leading cause of cancer-related deaths globally and oesophageal cancer is the sixth ...

AstraZeneca (AZ) has announced positive high-level results from a late-stage study of its AKT inhibitor Truqap (capivasertib) ...

Sanofi has announced the opening of its new €558m-backed manufacturing facility in Singapore, which the company says ...

Policymakers, payers, providers, patients and pharma are each uniquely able to impact health equity – and together, achieve ...

Galderma’s nemolizumab has been shown to improve the core signs and symptoms of prurigo nodularis, according to phase 3 ...

The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be ...

The EU Joint Clinical Assessment (JCA) is expected to require considerable time and resources from both countries and ...